Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pituitrin vs Norepinephrine for Vasoplegic Syndrome After Cardiac Surgery
NCT03106831Unknown
- Sponsor
- Beijing An Zhen Hospital
- Start
- Oct 2017
- Primary completion
- Dec 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of pituitrin in vasoplegic syndrome (VPS) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Rate of in-hospital acute renal injury at 30 days. Status: unknown.
02
Drugs
pituitrin
03
Conditions
vasoplegic syndrome (VPS)
Beyond the preview
Go deeper on NCT03106831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106831.